Skip to content

Assessment the effect of vitamin B6 supplementation on obesity and overweight

Assessment of the effect of oral pyridoxine hydrochloride supplement on anthropometric measurements, body composition, visceral adiposity index, glycemic and lipidemic risk factors and serum levels of leptin and adiponectin in obese and overweight women

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20181002041206N1
Enrollment
44
Registered
2018-10-31
Start date
2018-10-12
Completion date
Unknown
Last updated
2019-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity and overweight. Overweight and obesity

Interventions

Intervention 1: Intervention group: pyridoxine hydrochloride Supplement, 2 pills 40 mg per day for 8 weeks. Intervention 2: Control group: Placebo, starch, 2 pills 40 mg per day for 8 weeks.

Sponsors

Ahvaz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: Body mass index is over 25 kg / m2 No changes in weight over 5 kg over the past 3 months No history of diabetes, cardiovascular, brain, kidney, liver, respiratory, digestive, thyroid Do not use drugs that affect lipid profile and blood glucose and contraception Not taking any supplements including antioxidants, minerals, omega 3 and B6 within 2 months before the start of the study Non-use of cigarettes and alcohol Non-Lactation and Not pregnancy

Exclusion criteria

Exclusion criteria: Lack of patient collaboration at each stage of intervention Pregnancy during intervention Identify any of the diseases or use the drugs mentioned in the criteria for entry Start a weight loss diet

Design outcomes

Primary

MeasureTime frame
Body composition. Timepoint: The beginning and end of the study. Method of measurement: Body Composition Analyser.;Visceral Fat. Timepoint: The beginning and end of the study. Method of measurement: Calculation.;Blood Glucose. Timepoint: The beginning and end of the study. Method of measurement: Blood test.;Plasma Insulin. Timepoint: The beginning and end of the study. Method of measurement: Blood test.;Insulin resistance. Timepoint: The beginning and end of the study. Method of measurement: Calculation.;Total Cholesterol. Timepoint: The beginning and end of the study. Method of measurement: Blood test.;Triglycerides. Timepoint: The beginning and end of the study. Method of measurement: Blood test.;HDL Cholesterol. Timepoint: The beginning and end of the study. Method of measurement: Blood test.;LDL Cholesterol. Timepoint: The beginning and end of the study. Method of measurement: Calculation.;Leptin. Timepoint: The beginning and end of the study. Method of measurement: Blood test.;Adiponectin. Timepoint: The beginning and end of the study. Method of measurement: Blood test.

Secondary

MeasureTime frame
Body Mass Index. Timepoint: The beginning and end of the study. Method of measurement: body weight / hight square (kg/m2).;Waist Circumference. Timepoint: The beginning and end of the study. Method of measurement: measurment.;Hip circumference. Timepoint: The beginning and end of the study. Method of measurement: measurment.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFateme Mirzaey

Ahvaz University of Medical Sciences

mirzaey.f@ajums.ac.ir+98 61 3373 8383

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 16, 2026